AEROW trial (in cystic fibrosis)
Search documents
4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential Transcript
Seeking Alphaยท 2025-12-17 17:59
PresentationWith that, I will hand the call over to Julian Pei, Head of Investor Relations, who will make introductory comments.Hello, ladies and gentlemen. Thank you for standing by, and welcome to our investor webcast today. As a reminder, today's call is being recorded.Julian Pei Good morning, and thank you for joining our webcast to discuss interim Phase I data from our AEROW trial in cystic fibrosis. Before we begin, I encourage everyone to visit our Investor Relations website, where you can find a pre ...